Platelet–Leukocyte Aggregate and Interleukin‐6: An Emerging Perspective on a New Diagnostic and Therapeutic Clue for Acute Coronary Syndrome, A Case–Control Study
ABSTRACT Background and Aims Acute coronary syndrome (ACS) is one of the most important cardiovascular diseases. The rupture of atherosclerotic plaques in coronary arteries is considered the underlying pathophysiology of ACS. The interaction between cytokines and leukocytes in the presence of platel...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Health Science Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/hsr2.70209 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846100419000926208 |
|---|---|
| author | Mohammad Ghorbani Davood Bashash Mohamad Esmail Gheydari Mohammad Hossein Mohammadi Hojat Shahraki Somayeh Yazdanparast Keyvan Olazadeh Nazli Atashzar Mohsen Hamidpour |
| author_facet | Mohammad Ghorbani Davood Bashash Mohamad Esmail Gheydari Mohammad Hossein Mohammadi Hojat Shahraki Somayeh Yazdanparast Keyvan Olazadeh Nazli Atashzar Mohsen Hamidpour |
| author_sort | Mohammad Ghorbani |
| collection | DOAJ |
| description | ABSTRACT Background and Aims Acute coronary syndrome (ACS) is one of the most important cardiovascular diseases. The rupture of atherosclerotic plaques in coronary arteries is considered the underlying pathophysiology of ACS. The interaction between cytokines and leukocytes in the presence of platelets results in platelet–leukocyte aggregate (PLA). Monocytes, neutrophils, and cytokines are prime factors that promote PLA formation, which leads to atherosclerotic plaque progression and subsequent ACS development. This study aimed to investigate PLA (PMA and PNA) formation and cytokine (IL‐6 and TNF‐α) levels as well as the correlation between them in ACS patient samples to identify diagnostic markers. Methods A total of 30 patients with ACS and 24 healthy controls participated in this study. Flow cytometry analysis was performed to evaluate PLA formation, and the serum levels of cytokines were assessed by ELISA. The Pearson's correlation coefficient and ROC curve were calculated to investigate the correlation between the parameters and their diagnostic value, respectively. Results The results showed that PMA, PNA, and IL‐6 levels were significantly higher in ACS patients than in healthy controls. Additionally, TNF‐α levels were not significantly increased in the patient group. In addition, the Pearson's correlation coefficient results revealed a direct linear and statistically significant relationship between PMA‐IL‐6 and PNA‐IL‐6 as well as a direct linear but statistically nonsignificant relationship between IL‐6‐TNF‐α and PMA–PNA, whereas a convers linear but nonsignificant correlation was shown between PMA and TNF‐α and no correlation was detected between PNA and TNF‐α. Finally, ROC curve analysis revealed that the PMA, PNA, and IL‐6 can have diagnostic value. Conclusion In conclusion, the PMA, PNA, and IL‐6 can be used as powerful diagnostic markers in ACS patients. Therefore, disrupting PMA and PNA formation and inhibiting cytokine production may be new strategies for the treatment of ACS. However, further investigations are required to explore these parameters in the clinical diagnosis of ACS. |
| format | Article |
| id | doaj-art-f8710ca47bb14a4b829126d61a0e930d |
| institution | Kabale University |
| issn | 2398-8835 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Wiley |
| record_format | Article |
| series | Health Science Reports |
| spelling | doaj-art-f8710ca47bb14a4b829126d61a0e930d2024-12-30T08:46:33ZengWileyHealth Science Reports2398-88352024-12-01712n/an/a10.1002/hsr2.70209Platelet–Leukocyte Aggregate and Interleukin‐6: An Emerging Perspective on a New Diagnostic and Therapeutic Clue for Acute Coronary Syndrome, A Case–Control StudyMohammad Ghorbani0Davood Bashash1Mohamad Esmail Gheydari2Mohammad Hossein Mohammadi3Hojat Shahraki4Somayeh Yazdanparast5Keyvan Olazadeh6Nazli Atashzar7Mohsen Hamidpour8Department of Hematology and Blood Banking School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences Tehran IranDepartment of Hematology and Blood Banking School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences Tehran IranDepartment of Cardiology Taleqani Hospital, Shahid Beheshti University of Medical Sciences Tehran IranHSC Research Center ‐ Department of Hematology and Blood Banking School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences Tehran IranDepartment of Hematology and Blood Banking School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences Tehran IranDepartment of Hematology and Blood Banking School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences Tehran IranResearch Center for Social Determinants of Health, Research Institute for Endocrine Sciences Shahid Beheshti University of Medical Sciences Tehran IranDepartment of Cardiology Taleqani Hospital, Shahid Beheshti University of Medical Sciences Tehran IranHSC Research Center ‐ Department of Hematology and Blood Banking School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences Tehran IranABSTRACT Background and Aims Acute coronary syndrome (ACS) is one of the most important cardiovascular diseases. The rupture of atherosclerotic plaques in coronary arteries is considered the underlying pathophysiology of ACS. The interaction between cytokines and leukocytes in the presence of platelets results in platelet–leukocyte aggregate (PLA). Monocytes, neutrophils, and cytokines are prime factors that promote PLA formation, which leads to atherosclerotic plaque progression and subsequent ACS development. This study aimed to investigate PLA (PMA and PNA) formation and cytokine (IL‐6 and TNF‐α) levels as well as the correlation between them in ACS patient samples to identify diagnostic markers. Methods A total of 30 patients with ACS and 24 healthy controls participated in this study. Flow cytometry analysis was performed to evaluate PLA formation, and the serum levels of cytokines were assessed by ELISA. The Pearson's correlation coefficient and ROC curve were calculated to investigate the correlation between the parameters and their diagnostic value, respectively. Results The results showed that PMA, PNA, and IL‐6 levels were significantly higher in ACS patients than in healthy controls. Additionally, TNF‐α levels were not significantly increased in the patient group. In addition, the Pearson's correlation coefficient results revealed a direct linear and statistically significant relationship between PMA‐IL‐6 and PNA‐IL‐6 as well as a direct linear but statistically nonsignificant relationship between IL‐6‐TNF‐α and PMA–PNA, whereas a convers linear but nonsignificant correlation was shown between PMA and TNF‐α and no correlation was detected between PNA and TNF‐α. Finally, ROC curve analysis revealed that the PMA, PNA, and IL‐6 can have diagnostic value. Conclusion In conclusion, the PMA, PNA, and IL‐6 can be used as powerful diagnostic markers in ACS patients. Therefore, disrupting PMA and PNA formation and inhibiting cytokine production may be new strategies for the treatment of ACS. However, further investigations are required to explore these parameters in the clinical diagnosis of ACS.https://doi.org/10.1002/hsr2.70209acute coronary syndromeatherosclerosiscytokineplatelet‐monocyte aggregateplatelet‐neutrophil aggregate |
| spellingShingle | Mohammad Ghorbani Davood Bashash Mohamad Esmail Gheydari Mohammad Hossein Mohammadi Hojat Shahraki Somayeh Yazdanparast Keyvan Olazadeh Nazli Atashzar Mohsen Hamidpour Platelet–Leukocyte Aggregate and Interleukin‐6: An Emerging Perspective on a New Diagnostic and Therapeutic Clue for Acute Coronary Syndrome, A Case–Control Study Health Science Reports acute coronary syndrome atherosclerosis cytokine platelet‐monocyte aggregate platelet‐neutrophil aggregate |
| title | Platelet–Leukocyte Aggregate and Interleukin‐6: An Emerging Perspective on a New Diagnostic and Therapeutic Clue for Acute Coronary Syndrome, A Case–Control Study |
| title_full | Platelet–Leukocyte Aggregate and Interleukin‐6: An Emerging Perspective on a New Diagnostic and Therapeutic Clue for Acute Coronary Syndrome, A Case–Control Study |
| title_fullStr | Platelet–Leukocyte Aggregate and Interleukin‐6: An Emerging Perspective on a New Diagnostic and Therapeutic Clue for Acute Coronary Syndrome, A Case–Control Study |
| title_full_unstemmed | Platelet–Leukocyte Aggregate and Interleukin‐6: An Emerging Perspective on a New Diagnostic and Therapeutic Clue for Acute Coronary Syndrome, A Case–Control Study |
| title_short | Platelet–Leukocyte Aggregate and Interleukin‐6: An Emerging Perspective on a New Diagnostic and Therapeutic Clue for Acute Coronary Syndrome, A Case–Control Study |
| title_sort | platelet leukocyte aggregate and interleukin 6 an emerging perspective on a new diagnostic and therapeutic clue for acute coronary syndrome a case control study |
| topic | acute coronary syndrome atherosclerosis cytokine platelet‐monocyte aggregate platelet‐neutrophil aggregate |
| url | https://doi.org/10.1002/hsr2.70209 |
| work_keys_str_mv | AT mohammadghorbani plateletleukocyteaggregateandinterleukin6anemergingperspectiveonanewdiagnosticandtherapeuticclueforacutecoronarysyndromeacasecontrolstudy AT davoodbashash plateletleukocyteaggregateandinterleukin6anemergingperspectiveonanewdiagnosticandtherapeuticclueforacutecoronarysyndromeacasecontrolstudy AT mohamadesmailgheydari plateletleukocyteaggregateandinterleukin6anemergingperspectiveonanewdiagnosticandtherapeuticclueforacutecoronarysyndromeacasecontrolstudy AT mohammadhosseinmohammadi plateletleukocyteaggregateandinterleukin6anemergingperspectiveonanewdiagnosticandtherapeuticclueforacutecoronarysyndromeacasecontrolstudy AT hojatshahraki plateletleukocyteaggregateandinterleukin6anemergingperspectiveonanewdiagnosticandtherapeuticclueforacutecoronarysyndromeacasecontrolstudy AT somayehyazdanparast plateletleukocyteaggregateandinterleukin6anemergingperspectiveonanewdiagnosticandtherapeuticclueforacutecoronarysyndromeacasecontrolstudy AT keyvanolazadeh plateletleukocyteaggregateandinterleukin6anemergingperspectiveonanewdiagnosticandtherapeuticclueforacutecoronarysyndromeacasecontrolstudy AT nazliatashzar plateletleukocyteaggregateandinterleukin6anemergingperspectiveonanewdiagnosticandtherapeuticclueforacutecoronarysyndromeacasecontrolstudy AT mohsenhamidpour plateletleukocyteaggregateandinterleukin6anemergingperspectiveonanewdiagnosticandtherapeuticclueforacutecoronarysyndromeacasecontrolstudy |